News
When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...
The U.S. Department of Agriculture considers vaccinating poultry against bird flu amidst a major animal-health crisis, with ...
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...
Fred Kocher sits down with Lilly Wellington, Executive Director of the New Hampshire Commission On Aging, and Jennifer ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
1hon MSN
Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...
16h
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesCHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
Ethan Hunt's last mission? A new Superman? Happy Gilmore as a dad? Three genre-spanning Pedro Pascal movies, including a ...
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results